Abstracts

WAXING AND WANING HIV RISK: DYNAMICS OF PrEP ELIGIBILITY IN RAKAI, UGANDA

PrEP is based on the presence of substantial HIV risk (SHR) behaviors making PrEP eligibility and retention dynamic.  We used population-based data to describe longitudinal patterns of SHR of PrEP eligibility and identify factors associated with incidence, persistence and recurrence of PrEP eligibility. Between August 2011 – June 2018, 4 surveys including SHR-focused questions were…

POPULATION-LEVEL EFFECTIVENESS OF PrEP AMONG MSM AND TRANSGENDER PERSONS WITH STI

HIV PrEP is highly efficacious, but its effectiveness may be limited by poor adherence or discontinuation. Few studies have evaluated PrEP effectiveness outside of specific clinics or healthcare organizations.   We conducted a retrospective cohort study using King County, Washington STI partner services (PS) interview data collected January 2014 to August 2018.  During PS interviews, public…

TFV-DP IN DBS FOR PREGNANT/POSTPARTUM ADOLESCENT AND YOUNG WOMEN ON PrEP IN AFRICA

Pregnant/postpartum adolescent girls and young women (AGYW) in Africa are one of the populations at highest risk for HIV acquisition; yet, pharmacokinetic (PK) data for pre-exposure prophylaxis (PrEP) remains limited. Intracellular tenofovir-diphosphate (TFV-DP) concentration in red blood cells, measured via dried blood spots (DBS), has been used to monitor cumulative PrEP adherence in many settings.…

PUBLICLY FUNDED HIV PrEP IN BRITISH COLUMBIA: PROGRAM RETENTION AND NEW HIV DIAGNOSES

In January 2018, a province-wide HIV pre-exposure prophylaxis (PrEP) program was launched in British Columbia (BC), Canada, to complement the existing publicly-funded HIV treatment as prevention strategy. BC residents were eligible to receive publicly-funded emtricitabine-tenofovir DF through the centralized BC Centre for Excellence in HIV/AIDS program if they were at risk of HIV acquisition according to…

NOVEL CRITERIA FOR DIAGNOSING ACUTE HIV IN A MULTINATIONAL ART-INITIATION STUDY

Antiretroviral therapy (ART) initiation during acute HIV infection (AHI) limits HIV reservoirs, enhances reservoir decay, restricts viral genetic diversification and may facilitate post-ART control. Identifying and treating persons with AHI is highly desirable but logistically challenging. We describe the performance of new AHI diagnostic criteria for an ongoing multi-national study of ART initiation during AHI.…

IMPROVING CLASSIFICATION FOR RECENT HIV INFECTION USING TOP SCORING PAIRS

HIV cross-sectional incidence assays often measure characteristics of the antibody (Ab) response, such as titer, class, and avidity. These responses are affected by various factors including viral suppression. Since older guidelines recommended ART initiation later in infection, incidence algorithms often use viral suppression as a surrogate for non-recent infection. As new guidelines recommend ART initiation early…

STAGING OF HIV-1C INFECTION AMONG PATIENTS ON ART IN BOTSWANA USING PROVIRAL DNA

HIV genetic diversity increases during infection and can be used to infer time since infection; however published analyses have included only antiretroviral treatment (ART) naïve individuals. Demographic and clinical information from HIV-1C-infected patients were collected within the Botswana Combination Prevention Project from 2013 to 2018. HIV genetic sequencing efforts have been intensified under the PANGEA-HIV…